Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13

被引:0
作者
Weiss, MJ
Guo, C
Shusterman, S
Hii, G
Mirensky, TL
White, PS
Hogarty, MD
Rebbeck, TR
Teare, D
Urbanek, M
Brodeur, GM
Maris, JM
机构
[1] Childrens Hosp Philadelphia, Div Oncol, Abramson Pediat Res Ctr 902A, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA USA
[4] CRC, Genet Epidemiol Unit, Cambridge, England
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 2000年 / 35卷 / 06期
关键词
neuroblastoma; chromosome; human; pair; 16; genes; suppressor; tumor; genetics; linkage;
D O I
10.1002/1096-911X(20001201)35:6<526::AID-MPO5>3.0.CO;2-S
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Hereditary predisposition to develop neuroblastoma segregates as an autosomal dominant Mendelian trait. Procedure. We have performed linkage analysis on 10 families with neuroblastoma to localize a hereditary neuroblastoma predisposition gene (HNB1). Results. A single genomic interval at chromosome bands 16p12-p13 was consistent with linkage (lod = 3.46), and identification of informative recombinants defined a 25.9-cM critical region between D16S748 and D16S3068. Loss of heterozygosity was identified in 5/12 familial (42%) and 55/259 nonfamilial (21%) neuroblastomas at multiple 16p polymorphic loci. A 12.8-cM smallest region of overlap of deletions was identified within the interval defined by linkage analysis (tel-D16S764-D16S412-cen). Conclusions. Taken together, these data suggest that HNB1 is located at 16p12-p13 and that inactivation of this gene may contribute to the pathogenesis of nonfamilial neuroblastomas. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:526 / 530
页数:5
相关论文
共 13 条
  • [1] REVISIONS OF THE INTERNATIONAL CRITERIA FOR NEUROBLASTOMA DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT
    BRODEUR, GM
    PRITCHARD, J
    BERTHOLD, F
    CARLSEN, NLT
    CASTEL, V
    CASTLEBERRY, RP
    DEBERNARDI, B
    EVANS, AE
    FAVROT, M
    HEDBORG, F
    KANEKO, M
    KEMSHEAD, J
    LAMPERT, F
    LEE, REJ
    LOOK, AT
    PEARSON, ADJ
    PHILIP, T
    ROALD, B
    SAWADA, T
    SEEGER, RC
    TSUCHIDA, Y
    VOUTE, PA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) : 1466 - 1477
  • [2] CHOMPRET A, 1998, MED PEDIATR ONCOL, V31, pA211
  • [3] COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252
  • [4] KNUDSON AG, 1972, AM J HUM GENET, V24, P514
  • [5] Kruglyak L, 1996, AM J HUM GENET, V58, P1347
  • [6] KUSHNER BH, 1986, CANCER-AM CANCER SOC, V57, P1887, DOI 10.1002/1097-0142(19860501)57:9<1887::AID-CNCR2820570931>3.0.CO
  • [7] 2-7
  • [8] Molecular genetic analysis of familial neuroblastoma
    Maris, JM
    Kyemba, SM
    Rebbeck, TR
    White, PS
    Sulman, EP
    Jensen, SJ
    Allen, C
    Biegel, JA
    Brodeur, GM
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (12) : 1923 - 1928
  • [9] Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: A Children's Cancer Group study
    Maris, JM
    Weiss, MJ
    Guo, C
    Gerbing, RB
    Stram, DO
    White, PS
    Hogarty, MD
    Sulman, EP
    Thompson, PM
    Lukens, JN
    Matthay, KK
    Seeger, RC
    Brodeur, GM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (09) : 1888 - 1899
  • [10] MARIS JM, 1995, CANCER RES, V55, P4664